Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
Type:
Application
Filed:
August 21, 2018
Publication date:
January 3, 2019
Applicants:
Singapore Health Services PTE LTD., National University of Singapo
Inventors:
Stuart Alexander Cook, Sebastian Schaefer